Activity of tigecycline against clinical isolates of Staphylococcus aureus and extended-spectrum beta-lactamase-producing Escherichia coli in Granada, Spain.

Sorlózano, A; Gutiérrez, J; Salmerón, A; Luna, J D; Martínez-Checa, F; Román, J; Piédrola, G

Sorlózano, A; Gutiérrez, J; Salmerón, A; Luna, J D; Martínez-Checa, F; Román, J; Piédrola, G.

Affiliation

Sorlózano A; Department of Microbiology, University of Granada, Spain.

Int J Antimicrob Agents ; 28(6): 532-6, 2006 Dec.

Article in En | MEDLINE | ID: mdl-17045785

Subject(s)

Anti-Bacterial Agents/pharmacology; Escherichia coli Proteins/biosynthesis; Escherichia coli/drug effects; Methicillin Resistance; Minocycline/analogs & derivatives; Staphylococcus aureus/drug effects; beta-Lactamases/biosynthesis; Escherichia coli/enzymology; Humans; Methicillin/pharmacology; Microbial Sensitivity Tests/methods; Microbial Sensitivity Tests/standards; Minocycline/pharmacology; Tigecycline

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcus aureus / Beta-Lactamases / Methicillin Resistance / Escherichia coli Proteins / Escherichia coli / Minocycline / Anti-Bacterial Agents Type of study: Guideline Limits: Humans Country/Region as subject: Caribe ingles / Grenada Language: En Journal: Int J Antimicrob Agents Year: 2006 Document type: Article Affiliation country: Spain Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links